I.N. CHEREZOVA¹, N.KH. GABITOVA¹, I.V. OSIPOVA²

 ¹Kazan State Medical University Ministry of Health of Russia, Kazan

²Children’s Republican Clinical Hospital, Kazan

Contact details:

Gabitova N.Kh. — PhD (medicine), Associate Professor of the Department of Hospital Pediatrics

Address: 140 Orenburgskiy trakt, Kazan, Russian Federation, 420059, tel.: +7 (843) 269-67-69, e-mail: borismk1@rambler.ru

Hepatoblastoma is a common primary malignant tumor in children aged 0 to 4 years. In the structure of liver neoplasms, the pathology occupies 80% and has been steadily growing over the past 30 years with an annual increase of 4–5%. Risk factors for the development of hepatoblastoma include an increase in the survival rate of deeply premature babies, oxidative tissue damage associated with intensive therapy of low birth weight premature babies, and IVF. The disease has no specific complaints and characteristic clinical manifestations. The initial manifestations of hepatoblastoma are often hidden under a variety of mask diseases. It is accompanied by the absence of «oncological alertness» of local pediatricians, which determines the late diagnosis of the liver malignant neoplasm. The article presents an analysis of hepatoblastoma cases in young children over a ten-year period. The main initial clinical manifestations of the disease in early children are indicated. The effectiveness of modern methods of diagnosis and therapy of the liver malignant neoplasms in children is shown. A clinical example of successful treatment of this disease is given.

Key words: hepatoblastoma, young children.

REFERENCES

1. Spector L.G., Birch J. The epidemiology of hepatoblastoma. Pediatr Blood Cancer, 2012, vol. 59 (5), pp. 776–779.
2. Epidemiologiya zlokachestvennykh novoobrazovaniy u detey: osnovnye pokazateli v 2011–2016 gg., pod red. M.Yu. Rykova, V.G. Polyakova [Epidemiology of malignant neoplasms in children: main indicators in 2011–2016, ed. M.Yu. Rykov, V.G. Polyakov]. Moscow: Izd-vo Pervogo MGMU im. I.M. Sechenova, 2017. 208 p.
3. Shchegolev A.I., Tumanova U.N. Risk factors and morphological characteristics of hepatoblastoma. Mezhdunarodnyy zhurnal prikladnykh i fundamental’nykh issledovaniy, 2021, no. 1, pp. 24–29 (in Russ.).
4. Macias R.I.R., Armengol C., Marin J.J.G. Hepatoblastoma etiopathogenesis. J. Carcinog Mutagen, 2016, vol. 7 (1), pp. 1–4. DOI: 10.4172/2157-2518.1000e120
5. Spector L.G., Brown M.B., Wantman E., Gerard C.L., James P., Tonner J.P., Doody K., et all. Association of in Vitro Fertilization with Childhood Cancer in United States. Jama Pediatr, 2019, vol. 173 (6). DOI: 10.1001/jamapediatrics.2019.0392
6. Pruente J.R., Deike D.E., Lockart B., Gaebler-Spira D. Accociation of Hepatoblastoma, Prematurity and Cerebral Palsy: Case Reports. J Pediatr Rehabil Med, 2020, vol. 13 (1), pp. 185–188. Doi:10.3233/PRM-190662
7. Hager J. Hepatoblastoma Liver Cancer. Exon Publication, Brisbane, Australia, 2021. DOI: 10.36255/exonpublication.livercancer.2021.ch8
8. Nagae G., Yamamoto S., Fujita M., Fujita T., Nonaka A., Umeda T., Fukuda S.et all. Genetic and epigenetic basis of hepatoblastoma diversity. Nat Commun., 202, vol. 12 (1), p. 5423. DOI: 10.1038/s41467-021-25430-9
9. Adesina A.D., Lopez-Terrada D., Wong K. K., Gunaratne P., NguyenY., Pulliam J., Margolin J., Finegold M.J. Gene expression profiling reveals signatures characterizing Hystologic subtypes of hepatoblastoma and global deregulation in cell growth and survival pathways. Hum. Pathol., 2009, vol. 40 (6), pp. 843–853. DOI: 10.1016/j.humpath.2008.10.22
10. Arzumanian V.A., Kiseleva O.I., Poverennaya E.V. The Curious Case of the HepG2 Cell Line: 40 Years of Expertise. Int J Mol Sci, 2021, vol. 22 (23), p. 13135. DOI: 10.3390/ijms222313135
11. Rykov M.Yu., Polyakov V.G. Clinical manifestations and diagnosis of malignant neoplasms in children: what a pediatrician needs to know. Rossiyskiy vestnik perinatologii i pediatrii, 2017, vol. 62, no. 5, pp. 69–79 (in Russ.). DOI: 10.21508/1027-4065-2017-62-5-69-79
12. Sharma D., Subbarao G., Saxena R. Hepatoblastoma. Semin. Diagn. Pathol, 2017, vol. 34 (2), pp. 192–200. DOI: 10.1053/j.semdp 2016.12.015
13. Yhoshu E., A Lone Y., K Mahajan J., Bahadur Sing U. Hepatoblastoma with precocious puberty. J. Indian Assoc Pediatr Surg, 2019, vol. 24 (1), pp. 68–71. DOI: 10.4103/jiaps.JIAPS_102_18
14. Chattopadhyay S., Mukherjee S., Boler A., Sharma A., Sumitra Kumar Biswas Sarbani et al. Hepatoblastoma in the neonatal period: an unusual picture. J Citology, 2012, vol. 29 (4), pp. 252–254. DOI: 14.10.4103/0970-9371.103945
15. Thomas J., George C., Thomas P.A. Sase Report on neonatal hepatoblastoma. J. Pediatric Disord. Neonatal Care, 2018, vol. 1 (1). DOI: 10.18875/2638-3608.1.103
16. Saxena R., Quaglia A. Hepatoblastova. WHO Classification of Tumors. Digestive Sistem Tumors. 5th Ed. WHO press, 2019. Pp. 240–244.
17. Adora Dzhovi Fernandes, R.G. Vaysman Pinto. Hepatoblastoma: description of a clinical case. Novosti klinicheskoy tsitologii, 2019, vol. 23, no. 2, pp. 17–20 (in Russ.). DOI: 10.24411/1562- 4943-2019-10203
18. Pimenov R.I., Kerimov P.A., Kazantsev A.P., Rubanskaya M.V., Rubanskiy M.A., Bliznyukov O.P., Mikhaylova E.V. et al. Treatment of children with low-risk hepatoblastoma according to the classification of Children’s Hepatic tumor International Collaboration: a series of clinical observations. Rossiyskiy zhurnal detskoy gematologii i onkologii, 2020, vol. 7, no. 1, pp. 12–21 (in Russ.).
19. Hu H.M., Zang W.L., Wang Y.Z., Zang Y., Yi Y., Li F., Zhi T., Huang D.S. Treatment outcomes for hepatoblastoma children with pulmonary metastasis and extrapulmonary involvement: experience of 36 cases at a single institution. Trans Cancer Reseach of oct, 2020, vol. 9 (10), pp. 6402–6411. DOI: 10.21037/tcr–20-1876
20. Towbin A.J., Meyers R.L., Woodley H., Miyazaki O., Weldon C.B., Morland B., Hiyama E., Czauderna P., Roebuck D.J., Tiao G.M. PRETEXT 2017: Radiological staging system for primary liver malignancies in children, revised for the International Pediatric Liver Tumor Study (PHITT). Pediatr Radiol, 2018, vol. 48 (12), pp. 536–54. DOI: 10.1007/s00247-018-4228-3
21. Shi Y., Geller J.I., Ma I.T., Chavan R.S., Masand P.M., Taubin A.G., Chiantagumpala M. et al. Relapsed hepatoblastoma confined to the lung is effectively treated with pulmonary metastasec-tomy. J Pediatr Surg, 2016, vol. 51 (4), pp. 525–529. DOI: 10.1016/j.jped-surg.2015.10.053
22. Zhu C., Dong B., Chen X., Dong Q. Diagnosis and Ttreatment of Hepatoblastoma: An Update from the edited volume Liver Pathology Published: jan. 7th, 2020. DOI: 10.5772/intechopen.90830
23. Moiseenko R.A., Filin A.V., Metelin A.V., Shamanskaya T.V., Feoktistova E.V., Tereshchenko G.V., Roshchin V.Yu. et al. Results of liver transplantation in patients with high-risk hepatoblastoma. Collection of materials of the X Congress of NODGO. Rossiyskiy zhurnal detskoy gematologii i onkologii, 2019, pp. 106–107 (in Russ.).
24. Kerimov P.A., KazantsevA.P., Ryabov A.B., Rubanskiy M.A., Rybakova D.V. Surgical treatment of children with liver tumors. Collection of materials of the IΧ Interregional Meeting of the NODGO. Rossiyskiy zhurnal detskoy gematologii i onkologii, 2018, pp. 94–95 (in Russ.).